Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for UFPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 14.45M
March 31, 2026 1.458M
December 31, 2025 12.96M
September 30, 2025 32.55M
June 30, 2025 22.47M
March 31, 2025 10.99M
December 31, 2024 21.42M
September 30, 2024 17.66M
June 30, 2024 8.943M
March 31, 2024 8.922M
December 31, 2023 9.945M
September 30, 2023 15.25M
June 30, 2023 6.105M
March 31, 2023 -0.456M
December 31, 2022 14.92M
September 30, 2022 -2.423M
June 30, 2022 -2.987M
March 31, 2022 -5.55M
December 31, 2021 -0.50M
September 30, 2021 2.793M
June 30, 2021 4.72M
March 31, 2021 1.885M
December 31, 2020 6.988M
September 30, 2020 5.096M
June 30, 2020 4.863M
Date Value
March 31, 2020 3.722M
December 31, 2019 7.446M
September 30, 2019 8.466M
June 30, 2019 7.298M
March 31, 2019 2.241M
December 31, 2018 6.864M
September 30, 2018 4.572M
June 30, 2018 7.942M
March 31, 2018 -3.486M
December 31, 2017 0.957M
September 30, 2017 2.675M
June 30, 2017 0.78M
March 31, 2017 2.675M
December 31, 2016 1.598M
September 30, 2016 3.284M
June 30, 2016 1.228M
March 31, 2016 -4.01M
December 31, 2015 0.533M
September 30, 2015 1.018M
June 30, 2015 4.902M
March 31, 2015 -9.676M
December 31, 2014 1.778M
September 30, 2014 -1.721M
June 30, 2014 0.016M
March 31, 2014 -2.383M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 1.991B
AngioDynamics, Inc. 16.18M
Alphatec Holdings, Inc. -1.582M
AtriCure, Inc. 18.43M
Baxter International, Inc. 166.00M